Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China
· Delayed Price · Currency is CNY 22.15
-0.37 (-1.64%)
Apr 29, 2026, 3:00 PM CST
SHA:603579 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,453 | 4,787 | 2,510 | 2,825 | 2,731 | 4,478 | Upgrade
|
| Market Cap Growth | -5.34% | 90.74% | -11.16% | 3.44% | -39.01% | 8.83% | Upgrade
|
| Enterprise Value | 3,546 | 4,057 | 2,478 | 2,528 | 2,274 | 4,190 | Upgrade
|
| Last Close Price | 22.15 | 23.81 | 14.28 | 14.77 | 13.83 | 22.43 | Upgrade
|
| PE Ratio | 23.52 | 31.77 | 13.08 | 13.94 | 16.63 | 18.95 | Upgrade
|
| Forward PE | 24.61 | 22.95 | 11.69 | 12.79 | 12.94 | 15.62 | Upgrade
|
| PS Ratio | 2.75 | 3.04 | 1.57 | 1.52 | 1.36 | 1.71 | Upgrade
|
| PB Ratio | 1.54 | 1.72 | 1.25 | 1.43 | 1.46 | 2.52 | Upgrade
|
| P/TBV Ratio | 1.65 | 1.78 | 1.31 | 1.52 | 1.54 | 2.67 | Upgrade
|
| P/FCF Ratio | 87.35 | 76.09 | 147.10 | 11.09 | 20.06 | 22.79 | Upgrade
|
| P/OCF Ratio | 35.19 | 27.39 | 14.93 | 8.21 | 11.53 | 13.25 | Upgrade
|
| PEG Ratio | - | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | Upgrade
|
| EV/Sales Ratio | 2.19 | 2.58 | 1.55 | 1.36 | 1.13 | 1.60 | Upgrade
|
| EV/EBITDA Ratio | 24.60 | 26.28 | 12.29 | 9.86 | 11.14 | 14.31 | Upgrade
|
| EV/EBIT Ratio | 39.83 | 40.89 | 16.95 | 12.87 | 15.56 | 17.49 | Upgrade
|
| EV/FCF Ratio | 69.55 | 64.49 | 145.22 | 9.93 | 16.70 | 21.33 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.06 | 0.53 | 0.38 | 0.54 | 0.39 | Upgrade
|
| Debt / EBITDA Ratio | 1.91 | 1.09 | 5.33 | 2.95 | 4.93 | 2.31 | Upgrade
|
| Debt / FCF Ratio | 5.41 | 2.68 | 62.94 | 2.97 | 7.43 | 3.55 | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.23 | -0.33 | -0.54 | -0.48 | -0.44 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.51 | -4.18 | -3.31 | -4.13 | -4.38 | -2.66 | Upgrade
|
| Net Debt / FCF Ratio | -18.40 | -10.26 | -39.14 | -4.15 | -6.56 | -3.97 | Upgrade
|
| Asset Turnover | 0.45 | 0.43 | 0.45 | 0.55 | 0.60 | 0.84 | Upgrade
|
| Inventory Turnover | 6.24 | 7.12 | 7.38 | 7.39 | 6.09 | 7.25 | Upgrade
|
| Quick Ratio | 1.78 | 1.45 | 2.02 | 3.04 | 2.30 | 1.91 | Upgrade
|
| Current Ratio | 2.85 | 3.09 | 2.21 | 3.34 | 2.55 | 2.34 | Upgrade
|
| Return on Equity (ROE) | 7.05% | 6.25% | 9.62% | 10.58% | 9.03% | 13.30% | Upgrade
|
| Return on Assets (ROA) | 1.56% | 1.70% | 2.56% | 3.61% | 2.73% | 4.81% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.82% | 4.62% | 11.80% | 18.35% | 13.57% | 22.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 3.50% | 5.30% | 7.20% | 5.80% | 10.00% | Upgrade
|
| Earnings Yield | 3.96% | 3.15% | 7.65% | 7.17% | 6.01% | 5.28% | Upgrade
|
| FCF Yield | 1.14% | 1.31% | 0.68% | 9.01% | 4.98% | 4.39% | Upgrade
|
| Dividend Yield | 1.58% | - | 4.55% | 5.21% | 2.78% | 2.40% | Upgrade
|
| Payout Ratio | 34.55% | 41.09% | 104.10% | 38.51% | 63.08% | 30.57% | Upgrade
|
| Buyback Yield / Dilution | 4.42% | 8.24% | -14.21% | 0.18% | 4.53% | -2.16% | Upgrade
|
| Total Shareholder Return | 6.01% | 8.24% | -9.66% | 5.39% | 7.31% | 0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.